1. Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
   Jingwen Wei et al, 2022, BMC Pulmonary Medicine CrossRef
2. Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy
   Jung Hyun Nam et al, 2023, Thoracic Cancer CrossRef
3. Remodeling of metabolism and inflammation by exercise ameliorates tumor-associated anemia
   Regula Furrer et al, 2021, Science Advances CrossRef
4. Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey
   Peixin Dong et al, 2023, Clinical and Translational Oncology CrossRef
5. Evaluation and modifcation of lung immune prognostic index in patients with metastatic NSCLC treated by immunotherapy
   D. I. Yudin et al, 2023, Siberian journal of oncology CrossRef
6. Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort
   Hassan Abdelilah Tafenzi et al, 2023, BMC Cancer CrossRef
7. Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data
   Liling Huang et al, 2022, Future Oncology CrossRef
8. Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
   Ting Yuan et al, 2023, Cell Communication and Signaling CrossRef
9. Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study
   Ning Wan et al, 2024, European Journal of Cancer Care CrossRef
10. Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study
    Quan‐yao Li et al, 2024, Cancer Medicine CrossRef